OBJECTIVES:  To investigate (1) patterns of cancer centre routine follow-up (CC-FUP) care for breast, colorectal, gynecological, and prostate cancer survivors; (2) factors associated with receipt of CC-FUP; and (3) changes in CC-FUP over time. METHODS: From the Nova Scotia Cancer Registry, we identified all persons diagnosed in Nova Scotia, Canada, with an invasive breast, colorectal, gynecological, or prostate cancer between 01/01/2006 and 31/12/2013. We linked this population-based dataset, at the patient level, to cancer centre/clinic and census data. Next, we identified a non-metastatic survivor cohort (n=12,267) and developed decision rules to differentiate routine follow-up visits from non-routine visits during the follow-up care period (commencing one year post-diagnosis). Descriptive statistics were computed to describe patterns of care by patient and provider characteristics. Negative binomial regression was used to examine factors associated with the number of CC-FUP visits received and changes over time, adjusting for other covariates. RESULTS: Nearly half of survivors (48.4%) had at least one CC-FUP visit, which varied by disease site (range: 30.2-62.4%). Variation existed across providers, with six oncologists providing 34.7% of the CC-FUP visits to the study population. Disease site and stage at diagnosis were associated with receipt of CC-FUP care. For instance, gynecological cancer survivors had more visits [incidence rate ratio (IRR)=1.48, 95% confidence interval(CI)=1.34-1.64] whereas colorectal cancer survivors had less (IRR=0.45, 95%CI=0.40-0.51) compared to breast cancer survivors. Sex and geography did not impact the likelihood of receiving CC-FUP visits. Year of diagnosis was associated with receipt of CC-FUP care, with each successive calendar year associated with an 8% increase in visits (IRR=1.08, 95%CI=1.07-1.10). CONCLUSIONS: Despite evidence that follow-up care can be effectively and safely delivered in primary care, and intensifying demands on oncology services, many survivors continue to receive CC-FUP. Tailored interventions may improve survivors’ discharge to primary care post-treatment.